OrthoPediatrics Touts ‘Solid Start’ With Revenue Growth
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowWarsaw-based OrthoPediatrics Corp. (Nasdaq: KIDS) is reporting a first quarter net loss of $5 million, compared to a loss of $1.3 million during the previous quarter. Despite the drop, the medical device manufacturer says total revenue for the quarter rose 24 percent to $12.1 million.
The results represent just the second quarter for OrthoPediatrics as a public company, following its Initial Public Offering in October. Chief Executive Officer Mark Throdahl calls the results a "solid start to the year" and says the revenue growth was greater than anticipated.
"Since becoming a public company last October, we have exceeded anticipated growth in every quarter," said Throdahl. "While all of our product lines contributed, strong domestic scoliosis sales continued to outpace the industry, further establishing our leading market position in pediatric orthopedics."
You can connect to the full earnings report by clicking here.